Interactive Investor
>>

BiVictriX Therapeutics (LSE:BVX) Share Price

BVX

BiVictriX Therapeutics

UK company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XLON

-

Updated: -

Research

News & analysis

Regulatory news

Loading...

Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

BiVictriX Therapeutics PLC is a drug development company. It has developed its proprietary Bi-Cygni technology which utilises Antibody Drug Conjugates for the treatment of various cancers including Acute Myeloid Leukaemia. The main country of operation is in the UK.

LSE:BVX

GB00BNXH3K91

GBX

Loading...

Loading Comparison

Latest BVX News

BVX Regulatory News